Targeted human LILRB2 nano antibody and application thereof

The invention discloses an anti-LILRB2 nano antibody, nucleic acid for coding the nano antibody, an expression vector containing the nucleic acid, a pharmaceutical composition containing the nano antibody and application of the nano antibody to preparation of a medicine. 本发明公开了一种抗LILRB2的纳米抗体、编码所述纳米抗...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WANG RONGJUAN, ZHANG CHANG, WANG SHUANG, JIAO SHASHA, MAO GUANFAN, ZHANG JINCHAO
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WANG RONGJUAN
ZHANG CHANG
WANG SHUANG
JIAO SHASHA
MAO GUANFAN
ZHANG JINCHAO
description The invention discloses an anti-LILRB2 nano antibody, nucleic acid for coding the nano antibody, an expression vector containing the nucleic acid, a pharmaceutical composition containing the nano antibody and application of the nano antibody to preparation of a medicine. 本发明公开了一种抗LILRB2的纳米抗体、编码所述纳米抗体的核酸、包含所述核酸的表达载体、包含所述纳米抗体的药物组合物、以及制备药物的用途。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN115975029A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN115975029A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN115975029A3</originalsourceid><addsrcrecordid>eNrjZLAOSSxKTy1JTVHIKM1NzFPw8fQJcjJSyEvMy1dIzCvJTMpPqQQyUhQSCwpyMpMTSzLz8xRKMlKLUvPTeBhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJvLOfoaGppbmpgZGlozExagBKuS66</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Targeted human LILRB2 nano antibody and application thereof</title><source>esp@cenet</source><creator>WANG RONGJUAN ; ZHANG CHANG ; WANG SHUANG ; JIAO SHASHA ; MAO GUANFAN ; ZHANG JINCHAO</creator><creatorcontrib>WANG RONGJUAN ; ZHANG CHANG ; WANG SHUANG ; JIAO SHASHA ; MAO GUANFAN ; ZHANG JINCHAO</creatorcontrib><description>The invention discloses an anti-LILRB2 nano antibody, nucleic acid for coding the nano antibody, an expression vector containing the nucleic acid, a pharmaceutical composition containing the nano antibody and application of the nano antibody to preparation of a medicine. 本发明公开了一种抗LILRB2的纳米抗体、编码所述纳米抗体的核酸、包含所述核酸的表达载体、包含所述纳米抗体的药物组合物、以及制备药物的用途。</description><language>chi ; eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230418&amp;DB=EPODOC&amp;CC=CN&amp;NR=115975029A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230418&amp;DB=EPODOC&amp;CC=CN&amp;NR=115975029A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG RONGJUAN</creatorcontrib><creatorcontrib>ZHANG CHANG</creatorcontrib><creatorcontrib>WANG SHUANG</creatorcontrib><creatorcontrib>JIAO SHASHA</creatorcontrib><creatorcontrib>MAO GUANFAN</creatorcontrib><creatorcontrib>ZHANG JINCHAO</creatorcontrib><title>Targeted human LILRB2 nano antibody and application thereof</title><description>The invention discloses an anti-LILRB2 nano antibody, nucleic acid for coding the nano antibody, an expression vector containing the nucleic acid, a pharmaceutical composition containing the nano antibody and application of the nano antibody to preparation of a medicine. 本发明公开了一种抗LILRB2的纳米抗体、编码所述纳米抗体的核酸、包含所述核酸的表达载体、包含所述纳米抗体的药物组合物、以及制备药物的用途。</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAOSSxKTy1JTVHIKM1NzFPw8fQJcjJSyEvMy1dIzCvJTMpPqQQyUhQSCwpyMpMTSzLz8xRKMlKLUvPTeBhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJvLOfoaGppbmpgZGlozExagBKuS66</recordid><startdate>20230418</startdate><enddate>20230418</enddate><creator>WANG RONGJUAN</creator><creator>ZHANG CHANG</creator><creator>WANG SHUANG</creator><creator>JIAO SHASHA</creator><creator>MAO GUANFAN</creator><creator>ZHANG JINCHAO</creator><scope>EVB</scope></search><sort><creationdate>20230418</creationdate><title>Targeted human LILRB2 nano antibody and application thereof</title><author>WANG RONGJUAN ; ZHANG CHANG ; WANG SHUANG ; JIAO SHASHA ; MAO GUANFAN ; ZHANG JINCHAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN115975029A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG RONGJUAN</creatorcontrib><creatorcontrib>ZHANG CHANG</creatorcontrib><creatorcontrib>WANG SHUANG</creatorcontrib><creatorcontrib>JIAO SHASHA</creatorcontrib><creatorcontrib>MAO GUANFAN</creatorcontrib><creatorcontrib>ZHANG JINCHAO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG RONGJUAN</au><au>ZHANG CHANG</au><au>WANG SHUANG</au><au>JIAO SHASHA</au><au>MAO GUANFAN</au><au>ZHANG JINCHAO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Targeted human LILRB2 nano antibody and application thereof</title><date>2023-04-18</date><risdate>2023</risdate><abstract>The invention discloses an anti-LILRB2 nano antibody, nucleic acid for coding the nano antibody, an expression vector containing the nucleic acid, a pharmaceutical composition containing the nano antibody and application of the nano antibody to preparation of a medicine. 本发明公开了一种抗LILRB2的纳米抗体、编码所述纳米抗体的核酸、包含所述核酸的表达载体、包含所述纳米抗体的药物组合物、以及制备药物的用途。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN115975029A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Targeted human LILRB2 nano antibody and application thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T04%3A06%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG%20RONGJUAN&rft.date=2023-04-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN115975029A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true